|
⚲
|
| Insight Pharmaceuticals Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001467468 |
| Sale | 2009-06-17 ($32.3 M Offered, $32.3 M Sold) |
| Fund | |
| Phone | 8003447239 |
| Address | 1170 Wheeler Way, Suite 150 Langhorne, 19047 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Dennis Kinsey | |
| Daniel Reese | |
| Joseph Suprenuk | |
| C Stout | |
| Craig Hille | |
| Mickael Tukdarian | |
| Mark Poff | |
| Robert Monk |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Eichmann Eric
✚
|
0.0 | |
|
Eighth Notch, Inc.
✚
|
0.0 | |
|
EquityZen Growth Technology Fund LLC - Series 1133
✚
|
0.0 | |
|
Edition CLO Opportunity Fund II, L.P.
✚
|
0.0 | |
|
Einstein 2021, L.P.
✚
|
0.0 | |
|
Eisen Jacob
✚
|
0.0 | |
|
Elastico Tequila Grille
✚
|
0.0 | |
|
El Camino Real Medical, Inc.
✚
|
0.0 | |
|
El-Hage Nabil N.
✚
|
0.0 | |
|
Edwards James William
✚
|
0.0 |